PMC:2940017 / 16558-17127 JSONTXT

{"project":"TEST0","denotations":[{"id":"20495977-165-171-67278","span":{"begin":165,"end":167},"obj":"[\"8628876\"]"},{"id":"20495977-140-145-67279","span":{"begin":310,"end":311},"obj":"[\"10815665\"]"},{"id":"20495977-143-149-67280","span":{"begin":313,"end":315},"obj":"[\"17363594\", \"9762973\", \"8062241\"]"},{"id":"20495977-97-103-67281","span":{"begin":561,"end":563},"obj":"[\"10751361\"]"},{"id":"20495977-101-107-67282","span":{"begin":565,"end":567},"obj":"[\"12566167\"]"}],"text":"Increased vascular permeability has also been correlated with malignancy and has been evolving as a surrogate marker of tumour angiogenesis and, thus, tumour grade [14]. Higher permeability has been associated with higher tumour grade and has also been shown to decrease, responding to antiangiogenic therapy [3, 15–17]. Our results demonstrated significantly higher permeability values for both high-grade gliomas and lymphomas in comparison with healthy tissue. Both entities are characterised by a histopathologically proven blood-brain barrier disturbance [18, 19]."}

{"project":"0_colil","denotations":[{"id":"20495977-8628876-67278","span":{"begin":165,"end":167},"obj":"8628876"},{"id":"20495977-10815665-67279","span":{"begin":310,"end":311},"obj":"10815665"},{"id":"20495977-10751361-67281","span":{"begin":561,"end":563},"obj":"10751361"},{"id":"20495977-12566167-67282","span":{"begin":565,"end":567},"obj":"12566167"},{"id":"20495977-17363594-67280","span":{"begin":313,"end":315},"obj":"17363594"},{"id":"20495977-8062241-67280","span":{"begin":313,"end":315},"obj":"8062241"},{"id":"20495977-9762973-67280","span":{"begin":313,"end":315},"obj":"9762973"}],"text":"Increased vascular permeability has also been correlated with malignancy and has been evolving as a surrogate marker of tumour angiogenesis and, thus, tumour grade [14]. Higher permeability has been associated with higher tumour grade and has also been shown to decrease, responding to antiangiogenic therapy [3, 15–17]. Our results demonstrated significantly higher permeability values for both high-grade gliomas and lymphomas in comparison with healthy tissue. Both entities are characterised by a histopathologically proven blood-brain barrier disturbance [18, 19]."}

{"project":"2_test","denotations":[{"id":"20495977-8628876-29373463","span":{"begin":165,"end":167},"obj":"8628876"},{"id":"20495977-10815665-29373464","span":{"begin":310,"end":311},"obj":"10815665"},{"id":"20495977-17363594-29373465","span":{"begin":313,"end":315},"obj":"17363594"},{"id":"20495977-9762973-29373465","span":{"begin":313,"end":315},"obj":"9762973"},{"id":"20495977-8062241-29373465","span":{"begin":313,"end":315},"obj":"8062241"},{"id":"20495977-10751361-29373466","span":{"begin":561,"end":563},"obj":"10751361"},{"id":"20495977-12566167-29373467","span":{"begin":565,"end":567},"obj":"12566167"}],"text":"Increased vascular permeability has also been correlated with malignancy and has been evolving as a surrogate marker of tumour angiogenesis and, thus, tumour grade [14]. Higher permeability has been associated with higher tumour grade and has also been shown to decrease, responding to antiangiogenic therapy [3, 15–17]. Our results demonstrated significantly higher permeability values for both high-grade gliomas and lymphomas in comparison with healthy tissue. Both entities are characterised by a histopathologically proven blood-brain barrier disturbance [18, 19]."}

{"project":"MyTest","denotations":[{"id":"20495977-8628876-29373463","span":{"begin":165,"end":167},"obj":"8628876"},{"id":"20495977-10815665-29373464","span":{"begin":310,"end":311},"obj":"10815665"},{"id":"20495977-17363594-29373465","span":{"begin":313,"end":315},"obj":"17363594"},{"id":"20495977-9762973-29373465","span":{"begin":313,"end":315},"obj":"9762973"},{"id":"20495977-8062241-29373465","span":{"begin":313,"end":315},"obj":"8062241"},{"id":"20495977-10751361-29373466","span":{"begin":561,"end":563},"obj":"10751361"},{"id":"20495977-12566167-29373467","span":{"begin":565,"end":567},"obj":"12566167"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Increased vascular permeability has also been correlated with malignancy and has been evolving as a surrogate marker of tumour angiogenesis and, thus, tumour grade [14]. Higher permeability has been associated with higher tumour grade and has also been shown to decrease, responding to antiangiogenic therapy [3, 15–17]. Our results demonstrated significantly higher permeability values for both high-grade gliomas and lymphomas in comparison with healthy tissue. Both entities are characterised by a histopathologically proven blood-brain barrier disturbance [18, 19]."}